This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Ask the Experts: Key Considerations for Neuromuscular Blockade in Complex Patients

Ask the Experts: Key Considerations for Neuromuscular Blockade in Complex Patients

Format

Slide Lecture Series

Time to Complete

1 hour

Released

May 25, 2018

Expires

May 25, 2019
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Pharmacy Credits

Pharmacists may earn 1.00 CPE Credit (0.10 CEUs) by completing this course on the American Society of Health-System Pharmacists (ASHP) website. Please click here to go to the course (you will leave the myCME website, and free registration on the ASHP website is required). Your certificate will save on ASHP.org and will not be included in your myCME CME History.

Accredited Provider

This continuing medical education activity is provided by the American Society of Health-System Pharmacists (ASHP).

Commercial Supporter

Supported by an educational grant from Merck

Program Description

This activity focuses on current issues related to the use of neuromuscular blockade and reversal in complex patients in the postoperative and intensive care unit (ICU). The faculty address the key issues and provide practice pearls for physicians and pharmacists.

The content for this activity is based on questions and comments from participants at a recent educational symposium on this topic.

Intended Audience

This activity was planned to meet the educational needs of physicians, pharmacists, physician assistants, and nurse practitioners involved in critical care and postoperative settings.

Educational Objectives

At the conclusion of this application-based educational activity, participants should be able to:

  • Discuss the role of neuromuscular blockade in complex patients, including shivering in targeted temperature management (TTM), asthma, acute respiratory distress syndrome (ARDS), and end of life.
  • Compare methods to monitor neuromuscular blockade and sedation in patients receiving a neuromuscular blocking agent.
  • Apply recommendations from current guidelines in patient case scenarios.

Conflict Of Interest Disclosure Policy

In accordance with ACCME and ACPE Standards for Commercial Support, ASHP policy requires that all faculty, planners, reviewers, staff, and others in a position to control the content of this presentation disclose their financial relationships.

Faculty

Judith Jacobi, PharmD, BCCCP, DPNAP, FCCP, MCCM, Activity Chair
Critical Care Pharmacy Specialist
Indiana University Health Methodist Hospital
Indianapolis, IN

Dr. Jacobi has nothing to disclose.

Sean A. Nix, DO, FACOS
Director of Trauma
Saint Luke’s Hospital
Kansas City, MO

Dr. Nix has nothing to disclose.

Accredited Provider Disclosure

The planners and managers reported no financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Society of Health-System Pharmacists designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Instructions

In order to receive credit, participants must complete the post-test and program evaluation. Participants must also score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this program, please contact elearning@ashp.org.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue